Quillifoline

This classification denotes an analgesic agent with the molecular formula C21H24ClNO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 8JD13PH39Q, chemically known as 2-(p-chlorophenyl)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2h-benzo(a)quinolizine but more generally known as quillifoline, which bears U.S. National Institutes of Health Compound Identifier 160353. The European Medicines Agency schedules Quillifoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10195MIG. The term QUILLIFOLINE is an International Non-Proprietary Name. QUILLIFOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CLC1CCC(C2CC3N(CC2)CCC2C3CC(OC)C(OC)C2)CC1.